Services / Market data (roadmap)
Pricing and access data, coming next.
A proprietary life sciences pricing and market-access data product is on our roadmap, layered directly on top of the expert network. It isn't live yet.
What's actually true right now
- Built from real engagements: data will be derived directly from the same compliance-screened expert conversations already running through the platform.
- Healthcare first: starting where our bench is deepest, pricing, access, and formulary dynamics, with other verticals to follow.
If a specific data cut would change how your team works, tell us. That input is exactly what this roadmap needs.
Questions people ask
We don't have a firm date yet. It depends on how much expert-call volume we've built up to derive the data from. Early design partners will help shape the timeline.
Direct input into what data cuts matter most, and early access ahead of general availability. Reach out and we'll talk specifics.